SUNPHARMA.BOSUNPHARMA.BO
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
0.85%
↓ 86% below average
Average (9y)
6.23%
Historical baseline
Range
High:35.53%
Low:-6.78%
CAGR
-30.0%
Structural decline
| Period | Value |
|---|---|
| 2025 | 0.85% |
| 2024 | 35.53% |
| 2023 | 8.22% |
| 2022 | 1.41% |
| 2021 | 9.23% |
| 2020 | 0.64% |
| 2019 | -6.78% |
| 2018 | -4.37% |
| 2017 | -3.52% |
| 2016 | 21.06% |